Mindfulness-Based Pain Management (MBPM) for Patients With Chronic Musculoskeletal Pain
CompletedNot applicableNCT05199805
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Mindfulness-Based Pain Management (MBPM) is an eight-week behavioral medicine program. Based on the well-known Mindfulness-Based Stress Reduction (MBSR) program, it was specifically developed as an intervention for chronic pain. During the program, mindfulness exercises, gentle body exercises and body awareness and breathing exercises, as well as pain regulation methods are taught. Initial studies suggest efficacy of the program with regard to chronic pain, however, the effect of the standardized program in patients with chronic musculoskeletal pain has not yet been investigated in a clinical study. Therefore, the aim of this study is to investigate the MBPM program on pain acceptance in patients with chronic musculoskeletal pain. To this end, 40 patients with chronic (specific and non-specific) musculoskeletal pain will be randomly assigned to two study conditions. The intervention group will receive MBPM sessions of 150 minutes once a week over the course of 8 weeks, while the control group will receive standard therapy (waiting list). We hypothesize that patients will indicate a significantly higher pain acceptance after completing the program compared to patients not participating in the program.
Study details
- Official title
- Mindfulness-Based Pain Management (MBPM) for Patients With Chronic Musculoskeletal Pain: a Randomized Controlled Trial.
- Conditions
- Interventions
- Behavioral: Mindfulness-based pain management
- Sponsor
- Universität Duisburg-Essen
- Start date
- 2022-01-21
- Primary completion
- 2022-07-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Germany
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: \- Chronic specific or nonspecific musculoskeletal pain for at least 3 months Exclusion Criteria: New diagnosis within the last 3 months of: * Degenerative diseases (e.g., herniated disc, spinal stenosis) * Neurological diseases (e.g., neuropathies, multiple sclerosis) * Injuries of the spinal column (e.g. due to whiplash, vertebral body fractures, operations) Or severe concurrent diagnosis of: * Severe comorbid mental illness (e.g. addiction, severe depression) * Severe comorbid physical illness (e.g. cancer diagnosis within the last 5 years, severe preexisting disease of the cardiovascular system, insufficiency of other organs (kidney, liver, etc.), acute febrile infection, other severe neurological diseases such as epilepsy) * Pregnancy * Current pension application (for work incapacity, occupational disability, reduction in earning capacity, severe disability) * Simultaneous participation in other clinical trials
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05199805